Skip to main content
. 2021 Mar 12;16(3):e0247917. doi: 10.1371/journal.pone.0247917

Fig 3. Circulating miR-107 levels in different HCC subgroups.

Fig 3

Serum miR-107 levels do not significantly differ between patients with different liver disease etiology (A), tumor stage (B), tumor grading (C), surgical resection status (D) as well as between male and female patients (E) or patients with an unimpaired/impaired ECOG performance status (F). MiR-107 serum levels do not correlate with the size of HCC (G).